Updates are available Correction dated 2025-01-11
Click to view Correction: https://doi.org/10.1007/s00432-024-06056-y
-
Authors
Haller, Valerie
Reiff, Carina
Hamacher, Rainer
Kostbade, Karina
Kaths, Moritz
Treckmann, Juergen
Bertram, Stefanie
Zaun, Yasmin
Bauer, Sebastian
Falkenhorst, Johanna
-
Funding
Funding for this research was provided by:
Universitätsklinikum Essen
- License Information
-
More Information
Article History
Received: 9 August 2024
Accepted: 19 September 2024
First Online: 9 November 2024
Change Date: 4 December 2024
Change Type: Update
Change Details: In Table 1 of this article, row labels and their corresponding data were misaligned during the typesetting process. The correct alignment is now present.
Change Date: 11 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00432-024-06056-y
Declarations
:
: Johanna Falkenhorst: Consulting or Advisory role: Deciphera Pharmaceuticals, DIGIMED Verlag GmbH Sebastian Bauer: Honoraria: Novartis, Pharmamar, GlaxoSmithKline, Deciphera Consulting or Advisory Role: Blueprint Medicines, Bayer, Lilly, Deciphera, Nanobiotix, Daiichi Sankyo, Exelixis, Janssen-Cilag, ADC Therapeutics, Mundipharma, GlaxoSmithKline, Adcendo, Boehringer Ingelheim, IDRX Research Funding: Blueprint Medicines, Novartis, Incyte (Inst) Travel, Accommodations, Expenses: Pharmamar.
